CTMX
CytomX Therapeutics Inc
Price:  
3.25 
USD
Volume:  
2,499,659.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTMX Stock Forecast & Price Target

CTMX Stock Price Forecast

The average stock forecast for CytomX Therapeutics Inc (CTMX) in the next 12 months is 12.82 USD. This price target corresponds to an upside of 294.55%. The range of stock forecasts for CTMX is 6.06 - 16.80 USD. Based on the ratings of 14 analysts, the consensus recommendation for CTMX is BUY.
Target Low Average Median High
Price (USD) 6.06 12.82 12.24 16.80
Upside 86.46% 294.55% 276.62% 416.92%

Recommendation Trends

The latest consensus rating for CTMX is "BUY". This is the average recommendation of 14 analysts: 0 strong sell, 0 sell, 1 hold, 7 buy, 6 strong buy. In the previous period, 15 analysts also majorly recommmended "BUY" for CTMX.

CTMX Financial Stock Forecast

Revenue This Year
37.20M
-51.18%
from 76.20M
Revenue Next Year
44.83M
20.50%
from 37.20M
EPS This Year
-0.42
426.97%
from -0.08
EPS Next Year
-0.50
19.22%
from -0.42